Abstract
To the Editor: Schlaff et al. (Jan. 23 issue)1 discuss options for the management of uterine fibroids, mentioning a variety of interventional therapies and stating that data from randomized, controlled trials show that the effectiveness of these therapies is limited. We consider this statement to be misleading. On the contrary, since the publication of the 2008 practice guidelines from the American College of Obstetricians and Gynecologists, uterine-artery embolization has been recognized as one of three surgical options with level A evidence supporting its safety and effectiveness.2-4 All patients should be counseled about this surgical alternative during the process of informed . . .